Baxalta (now part of Takeda)

Baxalta was a global biopharmaceutical company specializing in medicines for rare and serious conditions, such as bleeding disorders and immune deficiencies. In 2016, it was acquired by Takeda Pharmaceutical Company, a large Japanese healthcare company. Today, Baxalta's innovative therapies are integrated into Takeda’s portfolio, helping treat patients with conditions that require specialized, high-quality biologic treatments. The merger expanded Takeda’s global reach and ability to provide advanced medicine for unmet medical needs.